130 related articles for article (PubMed ID: 11258794)
1. Production and validation of the pharmacokinetics of a single-chain Fv fragment of the MGR6 antibody for targeting of tumors expressing HER-2.
Turatti F; Mezzanzanica D; Nardini E; Luison E; Maffioli L; Bambardieri E; de Lalla C; Canevari S; Figini M
Cancer Immunol Immunother; 2001 Feb; 49(12):679-86. PubMed ID: 11258794
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of an anti-CD16 single-chain Fv fragment and construction of an anti-HER2/neu/anti-CD16 bispecific scFv that triggers CD16-dependent tumor cytolysis.
McCall AM; Adams GP; Amoroso AR; Nielsen UB; Zhang L; Horak E; Simmons H; Schier R; Marks JD; Weiner LM
Mol Immunol; 1999 May; 36(7):433-45. PubMed ID: 10449096
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct.
Pavlinkova G; Colcher D; Booth BJ; Goel A; Batra SK
Cancer Immunol Immunother; 2000 Jul; 49(4-5):267-75. PubMed ID: 10941910
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library.
Schier R; Marks JD; Wolf EJ; Apell G; Wong C; McCartney JE; Bookman MA; Huston JS; Houston LL; Weiner LM
Immunotechnology; 1995 May; 1(1):73-81. PubMed ID: 9373335
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts.
Pavlinkova G; Beresford GW; Booth BJ; Batra SK; Colcher D
J Nucl Med; 1999 Sep; 40(9):1536-46. PubMed ID: 10492377
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
7. Preparation of single chain variable fragment of MG(7) mAb by phage display technology.
Yu ZC; Ding J; Nie YZ; Fan DM; Zhang XY
World J Gastroenterol; 2001 Aug; 7(4):510-4. PubMed ID: 11819819
[TBL] [Abstract][Full Text] [Related]
8. Role of cross-linking agents in determining the biochemical and pharmacokinetic properties of Mgr6-clavin immunotoxins.
Dosio F; Arpicco S; Adobati E; Canevari S; Brusa P; De Santis R; Parente D; Pignanelli P; Negri DR; Colnaghi MI; Cattel L
Bioconjug Chem; 1998; 9(3):372-81. PubMed ID: 9576812
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
[TBL] [Abstract][Full Text] [Related]
10. Increased affinity leads to improved selective tumor delivery of single-chain Fv antibodies.
Adams GP; Schier R; Marshall K; Wolf EJ; McCall AM; Marks JD; Weiner LM
Cancer Res; 1998 Feb; 58(3):485-90. PubMed ID: 9458094
[TBL] [Abstract][Full Text] [Related]
11. Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display.
Kobayashi N; Kato Y; Oyama H; Taga S; Niwa T; Sun P; Ohtoyo M; Goto J
Steroids; 2008 Dec; 73(14):1485-99. PubMed ID: 18824188
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an anti-p185(HER2) (scFv-C(H)2-C(H)3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-D-GEEEK.
Vaidyanathan G; Jestin E; Olafsen T; Wu AM; Zalutsky MR
Nucl Med Biol; 2009 Aug; 36(6):671-80. PubMed ID: 19647173
[TBL] [Abstract][Full Text] [Related]
13. Functional human monoclonal antibodies of all isotypes constructed from phage display library-derived single-chain Fv antibody fragments.
Boel E; Verlaan S; Poppelier MJ; Westerdaal NA; Van Strijp JA; Logtenberg T
J Immunol Methods; 2000 May; 239(1-2):153-66. PubMed ID: 10821956
[TBL] [Abstract][Full Text] [Related]
14. Human antibody derivatives against the fibroblast activation protein for tumor stroma targeting of carcinomas.
Mersmann M; Schmidt A; Rippmann JF; Wüest T; Brocks B; Rettig WJ; Garin-Chesa P; Pfizenmaier K; Moosmayer D
Int J Cancer; 2001 Apr; 92(2):240-8. PubMed ID: 11291052
[TBL] [Abstract][Full Text] [Related]
15. Production of a human single-chain variable fragment antibody against esophageal carcinoma.
Xu MY; Xu XH; Chen GZ; Deng XL; Li J; Yu XJ; Chen MZ
World J Gastroenterol; 2004 Sep; 10(18):2619-23. PubMed ID: 15309706
[TBL] [Abstract][Full Text] [Related]
16. A linear region of a monoclonal antibody conformational epitope mapped on p185HER2 oncoprotein.
Orlandi R; Formantici C; Ménard S; Boyer CM; Wiener JR; Colnaghi M
Biol Chem; 1997 Nov; 378(11):1387-92. PubMed ID: 9426199
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of a recombinant anti-MUC1 scFv reactive with human carcinomas.
Denton G; Sekowski M; Spencer DI; Hughes OD; Murray A; Denley H; Tendler SJ; Price MR
Br J Cancer; 1997; 76(5):614-21. PubMed ID: 9303360
[TBL] [Abstract][Full Text] [Related]
18. High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment.
Willuda J; Honegger A; Waibel R; Schubiger PA; Stahel R; Zangemeister-Wittke U; Plückthun A
Cancer Res; 1999 Nov; 59(22):5758-67. PubMed ID: 10582696
[TBL] [Abstract][Full Text] [Related]
19. Isolation of scFv antibody fragments against HER2 and CEA tumor antigens from combinatorial antibody libraries derived from cancer patients.
Ayat H; Burrone OR; Sadghizadeh M; Jahanzad E; Rastgou N; Moghadasi S; Arbabi M
Biologicals; 2013 Nov; 41(6):345-54. PubMed ID: 23845693
[TBL] [Abstract][Full Text] [Related]
20. Construction of phage display libraries from reactive lymph nodes of breast carcinoma patients and selection for specifically binding human single chain Fv on cell lines.
Rothe A; Klimka A; Tur MK; Pfitzner T; Huhn M; Sasse S; Mallmann P; Engert A; Barth S
Int J Mol Med; 2004 Oct; 14(4):729-35. PubMed ID: 15375609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
